COVID-19中肺栓塞的D-二聚体阈值不应基于最大化Youden指数选择
本文针对Mouhat等在《欧洲呼吸杂志》发表的关于COVID-19患者肺栓塞诊断的研究进行评论,指出D-二聚体用于排除肺栓塞的阈值不应基于最大化Youden指数来选择,并强调COVID-19与肺栓塞症状重叠,亟需安全排除肺栓塞的简易诊断算法。
要点
- D-二聚体排除肺栓塞的阈值不应基于最大化Youden指数选择。
- COVID-19患者静脉血栓栓塞风险增加,但症状与肺栓塞重叠。
- 亟需能在COVID-19患者中安全排除肺栓塞的简易微创诊断算法。
核心结论
- D-二聚体排除肺栓塞的阈值不应基于最大化Youden指数来选择。
主要发现
- COVID-19患者发生静脉血栓栓塞的风险增加。
- COVID-19与肺栓塞的症状可能重叠,难以识别肺栓塞可能性较高的患者。
临床怎么用
- 在COVID-19患者中排除肺栓塞时,不应采用基于最大化Youden指数确定的D-二聚体阈值。
- 需关注能在COVID-19患者中安全排除肺栓塞的简易微创诊断算法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
D-dimer thresholds for ruling-out pulmonary embolism should not be selected based on the “optimal” Youden's index https://bit.ly/2Mfp4on The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has raised new challenges in the diagnosis of pulmonary embolism (PE) [1]. Patients with coronavirus disease 2019 (COVID-19) are at increased risk of developing venous thromboembolism, but symptoms of COVID-19 and PE may overlap, which makes it difficult to identify those with a higher likelihood of PE. Simple and minimally invasive diagnostic algorithms that can safely rule-out PE in patients with COVID-19 are urgently needed. Therefore, we read with interest the recent paper by Mouhat et al. [2] in the European Respiratory Journal.
引用
- Korevaar DA, van Es J. Pulmonary embolism in COVID-19: D-dimer threshold selection should not be based on maximising Youden's index. Eur Respir J. 2021. PMID: 33380510. doi:10.1183/13993003.04279-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。